Viewing Study NCT01743651


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2026-03-11 @ 7:35 AM
Study NCT ID: NCT01743651
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2012-11-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Sponsor: RVL Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module